Thursday, 26 July 2012

Genetic Technologies gets nod to sell cancer test in California



(Reuters) - Genetic Technologies Ltd said its lead cancer test BrevaGen has been cleared for sale in California, which it expects to be a large and significant market.





via Reuters: Health News Read More Here..

No comments:

Post a Comment